Related Experiment Video
Updated: May 17, 2025
06:10
An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
Published on: August 6, 2020
5.5K
G0S2 modulates normal vitreous-induced proliferation in endothelial cells
Yiwei Yin1,2,3, Li Pu1,2,4, Xi Yang5,6
1Department of Ophthalmology, Hunan Key Laboratory of Ophthalmology, Xiangya Hospital, Central South University, Changsha, China.
Communications Biology
|April 4, 2025
Summary
A newly identified protein, G0S2 (G0/G1 switch gene 2), is crucial for abnormal eye blood vessel growth. Targeting G0S2 may offer new treatments for vision loss and serve as a biomarker for eye cancers.
Area of Science:
- Ophthalmology
- Molecular Biology
- Oncology
Background:
- Abnormal blood vessel growth in the eye causes significant vision loss globally.
- The vitreous humor's role in promoting neovascularization is established but molecular drivers are unclear.
- Diabetic retinopathy is a leading cause of vision impairment linked to vitreous changes.
Purpose of the Study:
- To identify key molecular regulators of vitreous-induced blood vessel growth.
- To investigate the role of G0S2 (G0/G1 switch gene 2) in ocular neovascularization.
- To explore G0S2 as a potential therapeutic target and prognostic biomarker in eye diseases.
Main Methods:
- Gene expression analysis in blood vessel cells exposed to vitreous.
- Functional studies involving G0S2 knockdown in endothelial cells.
- Correlation analysis of G0S2 levels with patient survival in uveal melanoma.
Main Results:
- G0S2 expression is significantly upregulated by vitreous stimulation in blood vessel cells.
- Loss of G0S2 abrogates the pro-angiogenic response to vitreous.
- Elevated G0S2 levels correlate with poorer survival rates in uveal melanoma patients.
- An existing drug targeting G0S2 was identified.
Conclusions:
- G0S2 is a critical mediator of vitreous-induced angiogenesis in the eye.
- Targeting G0S2 presents a potential therapeutic strategy for neovascular eye diseases.
- G0S2 serves as a valuable prognostic biomarker for uveal melanoma.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:10Mechanism of Angiogenesis
5.1K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.1K
01:23Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K